Package 71205-504-30

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 71205-504-30
Digits Only 7120550430
Product NDC 71205-504
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-30)

Marketing

Marketing Status
Marketed Since 2020-11-13
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8ab86beb-3616-414c-92bf-25273a853a9e", "openfda": {"upc": ["0371205504304"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["42201f4a-8856-4499-8bc3-d18612b1ec34"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-30)", "package_ndc": "71205-504-30", "marketing_start_date": "20201113"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-60)", "package_ndc": "71205-504-60", "marketing_start_date": "20201113"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-90)", "package_ndc": "71205-504-90", "marketing_start_date": "20201113"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "71205-504_8ab86beb-3616-414c-92bf-25273a853a9e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71205-504", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20181108", "listing_expiration_date": "20261231"}